{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T11:24:09Z","timestamp":1743161049656},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,21]]},"DOI":"10.7759\/cureus.18153","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T12:18:57Z","timestamp":1632226737000},"source":"Crossref","is-referenced-by-count":5,"title":["A Rare Variant of Guillain-Barre Syndrome Following Ad26.COV2.S Vaccination"],"prefix":"10.7759","author":[{"given":"Zachary P","family":"Morehouse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sri A","family":"Jasti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Bing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison HJ","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome. Lancet. 2016, 388:717-27. 10.1016\/S0140-6736(16)00339-1","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.05.013","article-title":"Guillain-Barr\u00e9 syndrome and influenza vaccines: a meta-analysis","volume":"33","author":"Mart\u00edn Arias LH","year":"2015","unstructured":"Mart\u00edn Arias LH, Sanz R, S\u00e1inz M, Trece\u00f1o C, Carvajal A. Guillain-Barr\u00e9 syndrome and influenza vaccines: a meta-analysis. Vaccine. 2015, 33:3773-8. 10.1016\/j.vaccine.2015.05.013","journal-title":"Vaccine"},{"key":"ref3","article-title":"Guillain-Barr\u00e9 syndrome","volume":"87","author":"Walling AD","year":"2013","unstructured":"Walling AD, Dickson G. Guillain-Barr\u00e9 syndrome. Am Fam Physician. 2013, 87:191-7.","journal-title":"Am Fam Physician"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1693005","article-title":"Guillain-Barre syndrome","volume":"39","author":"Malek E","year":"2019","unstructured":"Malek E, Salameh J. Guillain-Barre syndrome. Semin Neurol. 2019, 39:589-95. 10.1055\/s-0039-1693005","journal-title":"Semin Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2013.01.005","article-title":"Guillain-Barr\u00e9 syndrome and variants","volume":"31","author":"Dimachkie MM","year":"2013","unstructured":"Dimachkie MM, Barohn RJ. Guillain-Barr\u00e9 syndrome and variants. Neurol Clin. 2013, 31:491-510. 10.1016\/j.ncl.2013.01.005","journal-title":"Neurol Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09742-2","article-title":"Axonal variants of Guillain-Barr\u00e9 syndrome: an update","volume":"268","author":"Shang P","year":"2021","unstructured":"Shang P, Zhu M, Wang Y, et al.. Axonal variants of Guillain-Barr\u00e9 syndrome: an update. J Neurol. 2021, 268:2402-19. 10.1007\/s00415-020-09742-2","journal-title":"J Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg B","year":"2014","unstructured":"van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014, 10:469-82. 10.1038\/nrneurol.2014.121","journal-title":"Nat Rev Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05523-5","article-title":"Guillain-Barr\u00e9 syndrome following BNT162b2 COVID-19 vaccine","author":"Trimboli M","year":"2021","unstructured":"Trimboli M, Zoleo P, Arabia G, Gambardella A. Guillain-Barr\u00e9 syndrome following BNT162b2 COVID-19 vaccine. Neurol Sci. 2021, 1-2. 10.1007\/s10072-021-05523-5","journal-title":"Neurol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.09.022","article-title":"Guillain-Barr\u00e9 syndrome","volume":"16","author":"Esposito S","year":"2017","unstructured":"Esposito S, Longo MR. Guillain-Barr\u00e9 syndrome. Autoimmun Rev. 2017, 16:96-101. 10.1016\/j.autrev.2016.09.022","journal-title":"Autoimmun Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16612","article-title":"Facial diplegia: a rare, atypical variant of Guillain-Barr\u00e9 syndrome and Ad26.COV2.S vaccine","volume":"13","author":"Jain E","year":"2021","unstructured":"Jain E, Pandav K, Regmi P, Michel G, Altshuler I. Facial diplegia: a rare, atypical variant of Guillain-Barr\u00e9 syndrome and Ad26.COV2.S vaccine. Cureus. 2021, 13:e16612. 10.7759\/cureus.16612","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242956","article-title":"Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1","volume":"14","author":"Patel SU","year":"2021","unstructured":"Patel SU, Khurram R, Lakhani A, Quirk B. Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep. 2021, 14:e242956. 10.1136\/bcr-2021-242956","journal-title":"BMJ Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.17843\/rpmesp.2020.374.5169","article-title":"Infectious agents in biological samples from patients with Guillain-Barr\u00e9 syndrome in Peru, 2018-2019 [Article in Spanish]","volume":"37","author":"Pachas P","year":"2020","unstructured":"Pachas P, Donaires F, Gavil\u00e1n RG, et al.. Infectious agents in biological samples from patients with Guillain-Barr\u00e9 syndrome in Peru, 2018-2019 [Article in Spanish]. Rev Peru Med Exp Salud Publica. 2020, 37:681-8. 10.17843\/rpmesp.2020.374.5169","journal-title":"Rev Peru Med Exp Salud Publica"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/71056-a-rare-variant-of-guillain-barre-syndrome-following-ad26cov2s-vaccination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:17Z","timestamp":1707507017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/71056-a-rare-variant-of-guillain-barre-syndrome-following-ad26cov2s-vaccination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.18153","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,21]]}}}